Effect of prophylactic antiviral intervention on T cell immunity in hepatitis B virus-infected pregnant women

[1]  G. Gartlehner,et al.  [Prevention of Mother-To-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy]. , 2022, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[2]  Yun-fei Gao,et al.  Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare , 2021, BMC Infectious Diseases.

[3]  A. Boonstra,et al.  The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for HBV? , 2020, Antiviral therapy.

[4]  H. Zhuang,et al.  A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01) , 2020, Journal of clinical and translational hepatology.

[5]  C. Coffin,et al.  Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics , 2020, Hepatology communications.

[6]  Songsong Lu,et al.  Increased proportion of functional subpopulations in circulating regulatory T cells in patients with chronic hepatitis B , 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  F. Cao,et al.  Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real‐life practice , 2019, Journal of viral hepatitis.

[8]  P. Easterbrook,et al.  Hepatitis B virus infection in children and adolescents. , 2019, The lancet. Gastroenterology & hepatology.

[9]  Jue Liu,et al.  Countdown to 2030: eliminating hepatitis B disease, China , 2019, Bulletin of the World Health Organization.

[10]  N. Vitoratos,et al.  Gestational Diabetes and T-cell (Th1/Th2/Th17/Treg) Immune Profile , 2018, In Vivo.

[11]  Q. Bian,et al.  Real‐world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load , 2018, Alimentary pharmacology & therapeutics.

[12]  B. McMahon,et al.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance , 2018, Hepatology.

[13]  R. Jhaveri,et al.  Call to Action: Prevention of Mother-to-Child Transmission of Hepatitis B in Africa. , 2018, The Journal of infectious diseases.

[14]  F. Cui,et al.  How to control highly endemic hepatitis B in Asia , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[15]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[16]  W. Lu,et al.  Relationship of Treg/Th17 balance with HBeAg change in HBeAg-positive chronic hepatitis B patients receiving telbivudine antiviral treatment , 2017, Medicine.

[17]  A. Funk,et al.  Systematic review with meta‐analysis: the risk of mother‐to‐child transmission of hepatitis B virus infection in sub‐Saharan Africa , 2016, Alimentary pharmacology & therapeutics.

[18]  Shuqin Zhang,et al.  Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. , 2016, The New England journal of medicine.

[19]  Xi Li,et al.  Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014. , 2016, Vaccine.

[20]  F. Cao,et al.  Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus , 2016, Journal of gastroenterology and hepatology.

[21]  B. McMahon,et al.  Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis , 2016, Hepatology.

[22]  M. Kumar,et al.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update , 2015, Hepatology International.

[23]  Gérard Krause,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[24]  X. Liu,et al.  T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance , 2015, Cell Death and Disease.

[25]  Wei Jiang,et al.  Telbivudine therapy may shape CD4+ T‐cell response to prevent liver fibrosis in patients with chronic hepatitis B , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[26]  Hua Zhang,et al.  Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice , 2014, Hepatology.

[27]  P. Chatterjee,et al.  Regulation of the Anti-Inflammatory Cytokines Interleukin-4 and Interleukin-10 during Pregnancy , 2014, Front. Immunol..

[28]  Yan-fang Jiang,et al.  Treatment with Telbivudine Positively Regulates Antiviral Immune Profiles in Chinese Patients with Chronic Hepatitis B , 2012, Antimicrobial Agents and Chemotherapy.

[29]  G. Borgia,et al.  Hepatitis B in pregnancy. , 2012, World journal of gastroenterology.

[30]  Hong Zhang,et al.  Virologic factors associated with failure to passive–active immunoprophylaxis in infants born to HBsAg‐positive mothers , 2012, Journal of viral hepatitis.

[31]  Lanjuan Li,et al.  Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. , 2011, Antiviral research.

[32]  H. Janssen,et al.  Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. , 2011, Journal of hepatology.

[33]  J. Jönsson,et al.  Systemic Reduction of Functionally Suppressive CD4dimCD25highFoxp3+ Tregs in Human Second Trimester Pregnancy Is Induced by Progesterone and 17β-Estradiol1 , 2009, The Journal of Immunology.

[34]  Ding‐Shinn Chen.  Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B. , 2009, Journal of hepatology.

[35]  D. Roelen,et al.  Evidence for a Selective Migration of Fetus-Specific CD4+CD25bright Regulatory T Cells from the Peripheral Blood to the Decidua in Human Pregnancy , 2008, The Journal of Immunology.

[36]  P. Arck,et al.  Progesterone During Pregnancy: Endocrine–Immune Cross Talk in Mammalian Species and the Role of Stress , 2007, American journal of reproductive immunology.

[37]  J. Brok,et al.  Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis , 2006, BMJ : British Medical Journal.

[38]  E. Kuipers,et al.  Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection , 2005, Hepatology.

[39]  R. Burk,et al.  Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. , 1994, The Journal of infectious diseases.

[40]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..